Delivery Order SPE2DB22D3301-SPE2DB24FY7AC

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a $7,169.35 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Lidocaine 5% patches. This delivery order falls under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceuticals and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,568.64, is to deliver Lidocaine 5% patches. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The $4,491.14 contract is for the supply of Lidocaine 5% patches to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,810.88, is for the delivery of Lidocaine 5% Patches. The contract is a Firm Fixed Price, Delivery Order contract and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $1,111.12 firm fixed price delivery order is for the supply of Lidocaine 5% patches to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,568.35 contract is for the delivery of Lidocaine 5% Patches in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a $3,877.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,454,933 units of Lidocaine 5% Patch 30s, with a period of performance ending on August 15, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in place through December 2025....
This is a $8,849.91 Firm Fixed Price delivery order contract awarded by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lidocaine 5% Patches, a pharmaceutical product used for pain relief. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY7AC
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the corporate office division of major pharmaceutical distributor Amerisourcebergen Corporation. The $1,548.67 contract is for the supply of Lidocaine 5% Patches, a topical anesthetic medication, to support the DLA's medical supply requirements. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense worldwide. The contract does not have a set-aside designation. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to efficiently fulfill critical medical product needs for federal government agencies.

Generated 8/25/24, 12:33 AM